Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Handoko

Showing results (351-360 of 414) with videos related to

Pageof 42
Sort By:
JAMA Cardiology|July 13, 2022
Diagnosis of Heart Failure With Preserved Ejection Fraction Among Patients With Unexplained DyspneaYogesh N V Reddy, David M Kaye, M Louis Handoko, et al.
Genes|October 17, 2020
Genetic Evaluation in a Cohort of 126 Dutch Pulmonary Arterial Hypertension PatientsLieke M van den Heuvel, Samara M A Jansen, Suzanne I M Alsters, et al.
American Journal of Respiratory and Critical Care Medicine|August 4, 2012
Dysregulated renin-angiotensin-aldosterone system contributes to pulmonary arterial hypertensionFrances S de Man, Ly Tu, M Louis Handoko, et al.
Open Heart|May 4, 2025
Incident HFpEF and time-dependent changes in markers of LVDD severity in women and men with preclinical LVDDAnne Margje Lisa Naomi van Ommen, Elisa Dal Canto, Ernest Diez Benavente, et al.
European Journal of Heart Failure|May 18, 2026
Intravenous IRON supplementation in Heart Failure with Preserved Ejection Fraction and iron deficiency (IRON-HFpEF): a comprehensive phase II multicentre placebo-controlled randomised clinical trialArno A van de Bovenkamp, Soufiane Nassiri, Frances S de Man, et al.
The European Respiratory Journal|September 2, 2009
Effects of exercise training in patients with idiopathic pulmonary arterial hypertensionF S de Man, M L Handoko, H Groepenhoff, et al.
Physiological Reports|November 20, 2023
Geranylgeranylacetone reduces cardiomyocyte stiffness and attenuates diastolic dysfunction in a rat model of cardiometabolic syndromeMark T Waddingham, Vasco Sequeira, Diederik W D Kuster, et al.
Circulation. Heart Failure|December 23, 2021
Right Ventricular and Right Atrial Function Are Less Compromised in Pulmonary Hypertension Secondary to Heart Failure With Preserved Ejection Fraction: A Comparison With Pulmonary Arterial Hypertension With Similar Pressure OverloadJessie van Wezenbeek, Azar Kianzad, Arno van de Bovenkamp, et al.
Physiological Reports|April 10, 2025
Mechanistic evaluation of ertugliflozin in patients with type 2 diabetes and heart failureYuliya Lytvyn, Rosalie A Scholtes, Eva M Boorsma, et al.
JHLT Open|July 18, 2025
Clinical relevance and outcome of routine endomyocardial biopsy to detect rejection after heart transplantationLeendert C Kieviet, Steven A Muller, Mariusz K Szymanski, et al.
Pageof 42

Showing results (351-360 of 414) with videos related to

Sort By:
Pageof 42
JAMA Cardiology|July 13, 2022
Diagnosis of Heart Failure With Preserved Ejection Fraction Among Patients With Unexplained DyspneaYogesh N V Reddy, David M Kaye, M Louis Handoko, et al.
Genes|October 17, 2020
Genetic Evaluation in a Cohort of 126 Dutch Pulmonary Arterial Hypertension PatientsLieke M van den Heuvel, Samara M A Jansen, Suzanne I M Alsters, et al.
American Journal of Respiratory and Critical Care Medicine|August 4, 2012
Dysregulated renin-angiotensin-aldosterone system contributes to pulmonary arterial hypertensionFrances S de Man, Ly Tu, M Louis Handoko, et al.
Open Heart|May 4, 2025
Incident HFpEF and time-dependent changes in markers of LVDD severity in women and men with preclinical LVDDAnne Margje Lisa Naomi van Ommen, Elisa Dal Canto, Ernest Diez Benavente, et al.
European Journal of Heart Failure|May 18, 2026
Intravenous IRON supplementation in Heart Failure with Preserved Ejection Fraction and iron deficiency (IRON-HFpEF): a comprehensive phase II multicentre placebo-controlled randomised clinical trialArno A van de Bovenkamp, Soufiane Nassiri, Frances S de Man, et al.
The European Respiratory Journal|September 2, 2009
Effects of exercise training in patients with idiopathic pulmonary arterial hypertensionF S de Man, M L Handoko, H Groepenhoff, et al.
Physiological Reports|November 20, 2023
Geranylgeranylacetone reduces cardiomyocyte stiffness and attenuates diastolic dysfunction in a rat model of cardiometabolic syndromeMark T Waddingham, Vasco Sequeira, Diederik W D Kuster, et al.
Circulation. Heart Failure|December 23, 2021
Right Ventricular and Right Atrial Function Are Less Compromised in Pulmonary Hypertension Secondary to Heart Failure With Preserved Ejection Fraction: A Comparison With Pulmonary Arterial Hypertension With Similar Pressure OverloadJessie van Wezenbeek, Azar Kianzad, Arno van de Bovenkamp, et al.
Physiological Reports|April 10, 2025
Mechanistic evaluation of ertugliflozin in patients with type 2 diabetes and heart failureYuliya Lytvyn, Rosalie A Scholtes, Eva M Boorsma, et al.
JHLT Open|July 18, 2025
Clinical relevance and outcome of routine endomyocardial biopsy to detect rejection after heart transplantationLeendert C Kieviet, Steven A Muller, Mariusz K Szymanski, et al.
Pageof 42